Our Team

 » Our Team | James R Berenson, MD : Founder & President

James R Berenson, MD Founder & President


Dr. Berenson is the Founder and Principal of ONCOtherapeutics, a prolific specialty practice in West Hollywood, CA ...

Read More
 » Our Team | Jessica Yataco : Chief Operating Officer

Jessica Yataco Chief Operating Officer


Jessica Yataco joined the Berenson Cancer Center in August 2018 with nearly 15 years of experience ...

Read More
 » Our Team | Matthew Brobeck : Director, Clinical Operations

Matthew Brobeck Director, Clinical Operations


Matthew Brobeck joined ONCOtherapeutics in 2023, bringing with him a wealth of experience in clinical research, healthcare administration...

Read More
 » Our Team | Andrea Limon : Project Manager

Andrea Limon Project Manager


Andrea Limon has specialized in the fields of oncology and diabetes. She joined ONCOtherapeutics in 2023, bringing her wealth...

Read More
 » Our Team | Halle Hunt : Project Manager

Halle Hunt Project Manager


Halle Hunt joined Oncotherapeutics in 2023. She gained valuable experience in the clinical research industry, notably as an Associate Clinic

Read More
 » Our Team | Ashley Del Dosso : Medical & Scientific Writer

Ashley Del Dosso Medical & Scientific Writer


Ashley Del Dosso is a medical and scientific writer at ONCOtherapeutics. She writes and edits clinical and basic research articles ...

Read More
 » Our Team | Tahmineh Safai : Clinical Data Coordinator

Tahmineh Safai Clinical Data Coordinator


Tahmineh Safai has a background in immune-oncology research with years of experience in biotechnology ...

Read More
 » Our Team | Nicole Lynn : Study Coordinator

Nicole Lynn Study Coordinator


Nicole Lynn is a Biochemist and Molecular Biologist who joined Oncotheraputics in 2023. Nicole brings with her a diverse understanding...

Read More

Streamline Your Process To Give Patients More

Let’s discuss how our comprehensive clinical study management services can streamline the execution of your clinical trial, affecting greater cost savings and expediting the development and delivery of innovative oncology treatments.